Literature DB >> 24746578

Does a central review platform improve the quality of radiotherapy for rectal cancer? Results of a national quality assurance project.

Ines Joye1, Maarten Lambrecht1, David Jegou2, Eszter Hortobágyi1, Pierre Scalliet3, Karin Haustermans4.   

Abstract

BACKGROUND AND
PURPOSE: Quality assurance (QA) for radiation treatment has become a priority since poorly delivered radiotherapy can negatively influence patient outcome. Within a national project we evaluated the feasibility of a central review platform and its role in improving uniformity of clinical target volume (CTV) delineation in daily practice.
MATERIAL AND METHODS: All Belgian radiotherapy departments were invited to participate and were asked to upload CTVs for rectal cancer treatment onto a secured server. These were centrally reviewed and feedback was given per e-mail. For each five consecutive patients per centre, the overlap parameter dice coefficient (DC) and the volumetric parameters volumetric ratio (RV) and commonly contoured volume (VCC) were calculated.
RESULTS: Twenty departments submitted 1224 eligible cases of which 909 were modified (74.3%). There was a significant increase in RV and VCC between the first ten patients per centre and the others. This was not seen for DC. Statistical analysis did not show a further significant improvement in delineation over the entire review period.
CONCLUSION: Central review was feasible and increased the uniformity in CTV delineation in the first ten rectal cancer patients per centre. The observations in this study can be used to optimize future QA initiatives.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Central review; Quality assurance; Radiotherapy; Rectal cancer; Target delineation

Mesh:

Year:  2014        PMID: 24746578     DOI: 10.1016/j.radonc.2014.03.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation.

Authors:  F Bartel; M van Herk; H Vrenken; F Vandaele; S Sunaert; K de Jaeger; N J Dollekamp; C Carbaat; E Lamers; E M T Dieleman; Y Lievens; D de Ruysscher; S B Schagen; M B de Ruiter; J C de Munck; J Belderbos
Journal:  Clin Transl Oncol       Date:  2018-06-06       Impact factor: 3.405

Review 2.  Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review.

Authors:  Michael V Sherer; Diana Lin; Sharif Elguindi; Simon Duke; Li-Tee Tan; Jon Cacicedo; Max Dahele; Erin F Gillespie
Journal:  Radiother Oncol       Date:  2021-05-11       Impact factor: 6.901

3.  Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal.

Authors:  Meritxell Arenas; Sebastià Sabater; Marina Gascón; Ivan Henríquez; M José Bueno; Àngels Rius; Àngels Rovirosa; David Gómez; Anna Lafuerza; Albert Biete; Jordi Colomer
Journal:  Radiat Oncol       Date:  2014-12-04       Impact factor: 3.481

4.  Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study.

Authors:  Maria A Gambacorta; Luca Boldrini; Chiara Valentini; Nicola Dinapoli; Gian C Mattiucci; Giuditta Chiloiro; Danilo Pasini; Stefania Manfrida; Nicola Caria; Bruce D Minsky; Vincenzo Valentini
Journal:  Oncotarget       Date:  2016-07-05

5.  Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.

Authors:  Pierfrancesco Franco; Francesca Arcadipane; Elisabetta Trino; Elena Gallio; Stefania Martini; Giuseppe Carlo Iorio; Cristina Piva; Francesco Moretto; Maria Grazia Ruo Redda; Roberta Verna; Vassiliki Tseroni; Cristina Bona; Gabriele Pozzi; Christian Fiandra; Riccardo Ragona; Oscar Bertetto; Umberto Ricardi
Journal:  Clin Transl Radiat Oncol       Date:  2018-06-11

6.  Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.

Authors:  Roy P J van den Ende; Femke P Peters; Ernst Harderwijk; Heidi Rütten; Liza Bouwmans; Maaike Berbee; Richard A M Canters; Georgiana Stoian; Kim Compagner; Tom Rozema; Mariska de Smet; Martijn P W Intven; Rob H N Tijssen; Jacqueline Theuws; Paul van Haaren; Baukelien van Triest; Dave Eekhout; Corrie A M Marijnen; Uulke A van der Heide; Ellen M Kerkhof
Journal:  Radiat Oncol       Date:  2020-02-18       Impact factor: 3.481

7.  Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy.

Authors:  Caroline Olsson; Tufve Nyholm; Elinore Wieslander; Eva Onjukka; Adalsteinn Gunnlaugsson; Johan Reizenstein; Stefan Johnsson; Ingrid Kristensen; Johan Skönevik; Magnus Karlsson; Ulf Isacsson; Anna Flejmer; Edvard Abel; Fredrik Nordström; Leif Nyström; Kjell Bergfeldt; Björn Zackrisson; Alexander Valdman
Journal:  Phys Imaging Radiat Oncol       Date:  2019-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.